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Mitochondrial Ca2+ overload is a critical, preceding
event in neuronal damage encountered during
neurodegenerative and ischemic insults. We found
that loss of PTEN-induced putative kinase 1
(PINK1) function, implicated in Parkinson disease, in-
hibits the mitochondrial Na+/Ca2+ exchanger (NCLX),
leading to impaired mitochondrial Ca2+ extrusion.
NCLX activity was, however, fully rescued by activa-
tion of the protein kinase A (PKA) pathway. We
further show that PKA rescues NCLX activity by
phosphorylating serine 258, a putative regulatory
NCLX site. Remarkably, a constitutively active phos-
phomimetic mutant of NCLX (NCLXS258D) prevents
mitochondrial Ca2+ overload and mitochondrial de-
polarization in PINK1 knockout neurons, thereby
enhancing neuronal survival. Our results identify an
mitochondrial Ca2+ transport regulatory pathway
that protects against mitochondrial Ca2+ overload.
Because mitochondrial Ca2+ dyshomeostasis is a
prominent feature of multiple disorders, the link be-
tween NCLX and PKA may offer a therapeutic target.
INTRODUCTION
Parkinson disease (PD) is the second most common neurode-
generative disease, characterized by a progressive loss of dopa-
minergic neurons in the substantia nigra pars compacta (SNc)
(Barbas, 2006; Fahn, 2003). Recent discoveries show that famil-
ial forms of PD are caused bymutations in several gene products
associated with mitochondrial quality control processes, rein-
forcing the major role of mitochondrial impairment in the patho-
genesis of PD (Bogaerts et al., 2008; Dagda and Chu, 2009). One
of the key models in characterizing mitochondrial pathology in
PD is based on a loss of PTEN-induced putative kinase 1376 Cell Reports 13, 376–386, October 13, 2015 ª2015 The Authors(PINK1) function (Gandhi et al., 2012). PINK1 is a serine/threo-
nine kinase localized to mitochondria that exerts a neuroprotec-
tive function, and its expression has been shown to be a
Ca2+-dependent process (Go´mez-Sa´nchez et al., 2014). Loss-
of-function mutations of PINK1 result in a series of mitochondrial
abnormalities implicated in the etiopathology and progression of
early-onset familial PD. These abnormalities include partial mito-
chondrial depolarization, increased oxidative stress, and mito-
chondrial fusion and fission defects (Valente et al., 2004;
Wood-Kaczmar et al., 2008).
A hallmark of PINK1 mutations related to PD is mitochondrial
calcium (mCa
2+) overload, which renders dopaminergic neurons
particularly vulnerable to injury (Gandhi et al., 2009). Adult dopa-
minergic neurons of the SNc are exposed to frequent and large
Ca2+ loads, due to their autonomous pacing activity that is
uniquely dependent on Ca2+ channels (Surmeier et al., 2012).
The mCa
2+ overload may therefore result from inability of the
mCa
2+ shuttling system to handle these loads (Chan et al.,
2007). The mCa
2+ transients in neurons are mediated by two
transporters: the mitochondrial calcium uniporter (MCU), which
mediates mCa
2+ influx, and the mitochondrial Na+/Ca2+
exchanger, which mediates mCa
2+ efflux (Baughman et al.,
2011; De Stefani et al., 2011; Palty et al., 2010). We have recently
identified the mitochondrial Na+/Ca2+ exchanger and linked it to
NCLX (Na+/Ca2+/Li+ exchanger), a member of the Na+/Ca2+
exchanger (NCX) family of transporters that share a common
catalytic core composed of a1 and a2 repeating domains (Nicoll
et al., 2013; Palty et al., 2004, 2010). However, it differs markedly
in the regulatory domain region, which, in contrast to other NCX
members, is much shorter and lacks allosteric Ca2+-binding do-
mains (Cai and Lytton, 2004). The mCa
2+ efflux by NCLX is much
slower than the MCU-mediated mCa
2+ influx (Drago et al., 2012).
Thus, NCLX is the rate-limiting system in controlling mCa
2+
surges (Palty et al., 2010). The profound inhibitory effect of
PINK1 deficiency on mCa
2+ removal suggests that in PD the ca-
pacity of the mitochondrial exchanger to remove mCa
2+ is
impaired. However, it is unknown whether the effects on mCa
2+
transients are mediated through direct interaction of PINK1
with NCLX or via an indirect phenomenon, such asmodulation of
the mCa
2+ influx machinery. Furthermore, it is uncertain whether
impaired mCa
2+ handling and the resulting mitochondrial depo-
larization and neuronal death encountered with PINK1mutations
can be rescued by other signaling pathways, such as the protein
kinase A (PKA) pathway, which shows diminished activity in
PINK1-deficient neuronal cells (Dagda et al., 2014).
Numerous studies support a major role of the cyclic AMP
(cAMP)/PKA signaling cascade in modulating mitochondrial
functions such as apoptosis, mitochondrial respiration, and
ATP production (Acin-Perez et al., 2009; Martin et al., 2005;
Technikova-Dobrova et al., 2001). Cyclic AMP produced by
plasma membrane adenylyl cyclase can diffuse throughout the
cell to set up localized gradients in subcellular organelles,
including mitochondria (DiPilato et al., 2004). In addition, cAMP
can be produced directly in themitochondrial matrix by a soluble
adenylyl cyclase (Chen et al., 2000). The cAMP is postulated to
activate PKA, which is detected in different mitochondrial com-
partments (Valsecchi et al., 2013). Interestingly, PKA exhibits a
prosurvival effect in PINK1-deficient cells, which is due in part
to the regulation of themitochondrial fission protein Drp1 (Dagda
et al., 2011). It is, however, unknown whether the prosurvival ef-
fects of PKA are linked to modulation of mCa
2+ signaling. Highly
coordinated interplay between cAMP and Ca2+ signaling, which
has been demonstrated in mitochondria (Di Benedetto et al.,
2013), suggests the involvement of PKA in the regulation of
mCa
2+ homeostasis.
In this study, we demonstrate that NCLX activity, impaired by
PINK1 deficiency, is rescued by PKA. We show that mCa
2+ efflux
occurs via direct phosphorylation of NCLX by PKA, revealing a
regulatory mode of mitochondrial Na+/Ca2+ exchange. Finally,
we find that modulation of the NCLX phosphorylation site by
PKA is essential and sufficient to protect PINK1-deficient
neurons from mitochondrial depolarization and dopamine-
induced cell death, underscoring the role of the exchanger and
its regulation via PKA in the pathogenesis of PD and potentially
in other neurodegenerative disorders of similar Ca2+-dependent
pathophysiology.
RESULTS
PINK1 Deficiency Causes Partial Mitochondrial
Depolarization and Inhibition of mCa
2+ Efflux
Previous studies suggested that PINK1 mutations linked to PD
lead to a partial decrease in mitochondrial membrane potential
(DJm) (Abramov et al., 2011; Gandhi et al., 2009). Another
prominent feature of these mutations is susceptibility to
mCa
2+ overload—a hallmark event in PD as well as other neuro-
degenerative and ischemic diseases (Cherra et al., 2013; Sur-
meier and Schumacker, 2013). We hypothesized that the path-
ological rise in mCa
2+ is specifically linked to impaired Ca2+
efflux by the mitochondrial Na+/Ca2+ exchanger (Gandhi
et al., 2009), whose molecular identity was only recently re-
vealed (Palty et al., 2010).
We first asked whether a knockdown of PINK1 in previously
characterized human neuroblastoma shPINK1 SH-SY5Y cells
(Dagda et al., 2009) mirrors the lowered DJm and impaired
mCa
2+ efflux, as previously reported (Abramov et al., 2011; Gan-Cdhi et al., 2009). DJm was recorded using the potentiometric
fluorescent dye tetramethylrhodamine methyl ester (TMRM),
where a complete depolarization can be induced by addition of
the mitochondrial uncoupler carbonyl cyanide-p-trifluorome-
thoxyphenylhydrazone (FCCP). Basal DJm in shPINK1 versus
control cells was determined by comparing the DJm before
and after the application of FCCP. Consistent with previous find-
ings, we recorded a significant reduction in basal DJm in stable
shPINK1 SH-SY5Y cells compared to control cells expressing a
nontargeting control plasmid (64% ± 11% of control) (Figures 1A
and 1B).
We next compared transient mCa
2+ responses in shPINK1
SH-SY5Y to those in control cells by using the mCa
2+ fluores-
cent dye Rhod-2 AM. Application of the P2Y receptor activator,
ATP, triggered cytosolic followed by mCa
2+ transients (Palty
et al., 2010) (Figure 1C). Consistent with a drop in DJm—the
major driving force for mCa
2+ uptake via MCU—the rate of
mCa
2+ influx was reduced by 2-fold in shPINK1 cells in com-
parison to control cells (Figures 1C and 1D). However, the
amplitude of the mCa
2+ influx phase remained unchanged (Fig-
ures 1C and 1E), showing that, although conducted at a slightly
slower rate, the capacity of mitochondria to take up Ca2+ re-
mains intact. In addition, no significant difference was observed
in basal mCa
2+ levels between control and PINK1-deficient cells
(Figure S1).
A much stronger effect of PINK1 knockdown was, however,
observed on the mCa
2+ efflux phase, as it triggered an 3.5-
fold decrease in mCa
2+ efflux rate compared to control (Fig-
ures 1C and 1F). Moreover, this reduction in mCa
2+ efflux
rate was coupled to an 4-fold reduction in the amplitude of
the mCa
2+ efflux phase (Figures 1C and 1G). Hence, whereas
Ca2+ efflux fully recovered the mCa
2+ to resting levels in con-
trol cells, mitochondria of PINK1-deficient cells, in contrast,
failed to effectively extrude Ca2+ and it remained elevated
above resting levels. Taken together, our results, consistent
with previous studies, suggested that PINK1 deficiency re-
duces mCa
2+ uptake (Gandhi et al., 2009; Heeman et al.,
2011) but has a larger effect on both the rate and amplitude
of the mCa
2+ efflux phase, thereby triggering a net reduction
in mCa
2+ extrusion.
We next determined whether PINK1 knockdown caused
changes in expression of NCLX in shPINK1 versus control cells.
Immunoblot analysis of shPINK1 cells showed similar levels of
NCLX expression compared to control cells (Figures 1H and
1I), indicating that overload of mCa
2+ is not caused by a decrease
in NCLX expression but is most likely due to inhibition of NCLX
activity in PINK1-deficient cells.
The profound effect of shPINK1 on mCa
2+ efflux suggests that
this kinase may act by directly interacting with the exchanger,
NCLX. Bioinformatic analysis that we conducted using the Scan-
site algorithm (Obenauer et al., 2003), however, did not identify
potential PINK1 binding or phosphorylation sites on NCLX.
Consistent with this analysis and previous study that did not
identify NCLX interaction with PINK1 (Rakovic et al., 2011),
immunoprecipitation of c-myc-tagged NCLX followed by mass
spectrometry (MS) analysis did not identify a pull-down of
PINK1 by NCLX (Table S1), arguing against a direct interaction
between these two proteins.ell Reports 13, 376–386, October 13, 2015 ª2015 The Authors 377
Figure 1. PINK1 Knockdown Triggers Mitochondrial Depolarization and Reduces mCa
2+ Efflux
(A) Representative fluorescence traces ofDJmdetermined in PINK1 knockdown SH-SY5Y cells (shPINK1) and control cells loaded and continuously superfused
with TMRM (25 nM). FCCP (1 mM) was used to calibrate the signal by inducing a complete depolarization.
(B) Quantification of the resting DJm of (A); shPINK1 cells (n = 5) show a reduction in basal DJm compared to control cells (n = 9).
(C) Representative ATP-dependent fluorescence traces of mCa
2+ responses in shPINK1 cells versus control cells loaded with Rhod-2 AM (5 mM).
(D and E) Averaged rate and amplitude of the mCa
2+ influx phase of (C) (n = 13 and n = 10 for shPINK1 and control cells, respectively).
(F and G) Averaged rate and amplitude of the mCa
2+ efflux phase of (C) (n = 13 and n = 10 for shPINK1 and control cells, respectively). Note that PINK1 silencing in
SH-SY5Y cells has a larger effect on both the rate and amplitude of the mCa
2+ efflux than the mCa
2+ influx phase.
(H and I) Immunoblot analysis of shPINK1 cells (n = 3) shows a similar level of NCLX expression compared to control cells (n = 3). Actin was used as a loading
control. All bar graph data represent mean ± SEM. *p < 0.05, **p < 0.01; ns, not significant. See also Figure S1.PKA Activation Rescues mCa
2+ Efflux and Mitochondrial
Membrane Depolarization Triggered by PINK1
Deficiency
We next sought to determine whether we could rescue mCa
2+
efflux of PINK1-deficient SH-SY5Y cells. Because the above re-
sults do not support a direct interaction of PINK1 and NCLX, we
reasoned that such rescue of NCLX activity may be mediated by
another signaling pathway. Among the potential signaling path-
ways the PKA pathway emerged as a leading signaling candi-
date able to rescue several parameters of PINK1 deficiency,
most notably DJm (Dagda et al., 2011). To determine whether
PKA regulates NCLX activity, we monitored mCa
2+ transients
and DJm in PINK1-deficient SH-SY5Y cells versus control cells
that were pre-exposed to the PKA agonist forskolin. Application
of forskolin led to a full recovery of DJm in shPINK1 cells up to
the control values, but was not followed by a change in DJm of
control cells (Figures 2A and 2B).
Consistent with the role of DJm in controlling the driving force
for mCa
2+ influx, DJm rescue by PKA activation was followed by
recovery of mCa
2+ influx rates in shPINK1 SH-SY5Y cells (Figures
2C and 2D). Importantly, activation of PKA further led to a much
stronger, 6-fold increase in mCa2+ efflux rate in shPINK1 SH-
SY5Y cells, thereby fully restoring mCa
2+ efflux to rates moni-
tored in control cells (Figures 2C and 2E). We also found that
application of forskolin could enhance, to a lesser extent, by378 Cell Reports 13, 376–386, October 13, 2015 ª2015 The Authors2-fold, the rate of mCa2+ efflux but not mCa2+ influx of control
cells, thus supporting a role of PKA in regulating NCLX rather
than MCU (Figures 2D and 2E). To further ascertain that forskolin
acts via PKA, cells were cotreated with forskolin and the PKA in-
hibitor H89. Note that their coapplication completely abolished
mCa
2+ efflux activation, both in shPINK1 and control cells (Fig-
ures 2D and 2E), lending further support that the effect of forsko-
lin on NCLX is mediated via PKA.
Serine 258 Is the Putative PKA Phosphorylation Site
of NCLX
PKA can regulate NCLX indirectly through other signaling path-
ways or by direct phosphorylation of the exchanger. To deter-
mine whether PKA acts directly on NCLX, we screened for puta-
tive PKA phosphorylation sites employing the Scansite 3
algorithm. A high score of probability was given to serine residue
258 (S258). The potential of S258 to undergo PKA-dependent
phosphorylation was further supported by NetPhosK 1.0 (Blom
et al., 2004) and pkaPS analysis (Neuberger et al., 2007), which
indicated that S258 is part of a PKA signature sequence, RRXSY
(where Y is a hydrophobic amino acid, leucine in this case). Fig-
ure 3A shows the predicted transmembrane topology model of
NCLX depicting the putative S258 PKA phosphorylation site.
This putative phosphorylation site is located within the hydro-
philic loop of the exchanger, which in other NCX superfamily
Figure 2. PKA Activation Rescues DJm and
Ca2+ Efflux in PINK1-Deficient Cells
(A) Representative fluorescence traces of DJm
determined in shPINK1 and control cells loaded
and continuously superfused with TMRM in the
presence or absence of the pharmacological acti-
vator of PKA, forskolin (FSK). FCCP induced com-
plete depolarization and was used to calibrate the
signal.
(B) Quantification of restingDJm in shPINK1 (n = 6)
and control cells (n = 4) treated with vehicle (DMSO)
versus forskolin (50 mM, 2 hr). Significant repolari-
zation of mitochondria was recorded in shPINK1
cells upon forskolin treatment.
(C) Representative fluorescence traces of mCa
2+
responses in Rhod-2 AM-loaded shPINK1 and
control cells following application of ATP (100 mM).
Cells were pretreated either with vehicle (DMSO),
forskolin (50 mM, 15 min), or forskolin upon expo-
sure to the PKA inhibitor H89 (10 mM, 1 hr).
(D and E) Averaged rates of the mCa
2+ influx and
efflux phases of Figure 3C, respectively. Forskolin
fully recovered both mCa
2+ influx and efflux in
shPINK1 cells (n = 7) to control values; H89 fully
prevented the activation of Ca2+ efflux by forskolin
in shPINK1 cells (n = 9). Forskolin treatment in
control cells (n = 5) increased only the rate of mCa
2+
efflux; this effect was prevented by pretreating the
control cells with H89 as well (n = 3). All bar graph
data represent mean ± SEM. *p < 0.05, **p < 0.01,
***p < 0.001.members serves as the major regulatory site responding to allo-
sterically bound Ca2+ (the so-called CBD1 and CBD 2) (Nicoll
et al., 2013). NCLX is devoid of these Ca2+ binding sites, but
has instead the putative PKAphosphorylation site at this domain.
To examine whether S258 indeed undergoes phosphorylation,
and whether it is phosphorylated in a PKA-dependent manner,
we employed MS analysis of c-myc-tagged NCLX treated with
forskolin, with or without H89, as described in Figure 2. MS anal-
ysis identified phosphorylation of S258 in forskolin-treated but
not H89-cotreated NCLX (Figure 3B). Furthermore, in vitro anal-
ysis of immunopurified NCLX revealed that S258 is phosphory-
lated in the presence of the PKA catalytic subunit as well, sup-
porting direct phosphorylation of NCLX by PKA (Figure 3B).
To further determine whether phosphorylation at S258 could
explain the functional effects of PKA on NCLX activity, we gener-
ated NCLXS258A and NCLXS258D mutants to mimic phosphoryla-
tion-deficient and constitutively phosphorylated residues,
respectively. To ascertain that the mutation did not affect the
expression or localization of NCLX, we employed immunoblot
analysis of expression in total and mitochondrial cell fractions.
As shown in Figure 3C, the expression and localization of themu-
tants were similar to that of NCLXWT.Cell Reports 13, 376–386We next monitored mCa
2+ efflux activity
of the NCLX mutants versus NCLXWT by
applying a silencing-rescue paradigm
(Palty et al., 2010) of knocking down
endogenous NCLX expression while ex-
pressing NCLX constructs in cells coex-pressing the mCa
2+ sensor mito-Pericam. Consistent with our
previous studies (Palty et al., 2010), silencing of endogenous
NCLX expression in HEK293T cells, using small hairpin RNA
(shRNA) targeted against the 30 UTR of NCLX, was followed by
an 2.5-fold reduction in mCa2+ efflux rates compared to cells
transfected with control shRNA, which was fully rescued by
overexpression of NCLXWT (Figure S2A).
Similar to NCLXWT, phosphomimicking mutant NCLXS258D
was able to fully rescue mCa
2+ efflux in shNCLX-treated cells.
On the contrary, phosphodeficient mutant NCLXS258A failed to
upregulate mCa
2+ efflux, with an 3.5-fold decrease in activity
compared to NCLXS258D (Figures 3D and 3E). In addition, no dif-
ference in basal mCa
2+ levels was observed between the mu-
tants and NCLXWT (Figure S2B).
The difference in activity between NCLXS258A and NCLXS258D
mutants was further confirmed, applying the same silencing-
rescue paradigm (Palty et al., 2010), in digitonin-permeabilized
HEK293T cells. The mitochondria of permeabilized HEK293T
cells transiently expressing mito-Pericam and shNCLX, alone
or in a combination with NCLX constructs, were loaded with
Ca2+, andCa2+ effluxwas initiated by addition of Na+, in the pres-
ence of the MCU blocker Ruthenium red, as previously, October 13, 2015 ª2015 The Authors 379
Figure 3. PKA Activates mCa
2+ Efflux through a Phosphorylation Site on NCLX
(A) The putative transmembrane topology model of NCLX obtained using TopPred (von Heijne, 1992). NCLX contains an N-terminal mitochondrial targeting
sequence and two conserved catalytic transmembrane domains, a1 and a2. The putative PKA phosphorylation site Ser258 is located in the hydrophilic loop of the
exchanger and is part of the PKA consensus sequence.
(B) Collision-induced dissociation MS/MS spectrum of the phosphorylated NCLX peptide 256RGpSLFCPMPVTPEILSDSEEDR277 (where p indicates phos-
phorylation of S258) found only in c-myc-tagged NCLX isolated from cells treated with the PKA activator forskolin (middle panel) or following direct in vitro
incubation with a recombinant PKA catalytic subunit (PKAca) (lower panel) but not in the presence of the PKA inhibitor H89 (upper panel). m/z, mass-to-
charge ratio. bn and yn denote N- and C-terminal fragments, respectively. Fragment ions that contain a mass shift as a result of phosphorylation are marked
in red.
(C) Immunoblot analysis of NCLX expression in total lysate (T) and isolated mitochondria (M) in HEK293T cells transfected with either NCLXWT-, NCLXS258A-, or
NCLXS258D-coding plasmids or empty vector (pcDNA3.1+). COXIV-1 was used as a mitochondrial marker. NCLX is identified as a 100-kDa dimer in the mito-
chondrial fraction. Similar to NCLXWT, overexpression of the constructs NCLXS258A and NCLXS258D results in mitochondrial targeted expression, and NCLX
expression is not affected by the mutation.
(D) Representative fluorescence traces of mCa
2+ responses upon application of ATP to HEK293T cells transiently expressing the mCa
2+ sensor mito-Pericam,
NCLX shRNA, and NCLXWT or mutant NCLX (NCLXS258A or NCLXS258D).
(E) Quantification of mCa
2+ efflux rates of (D). NCLXS258D (n = 10) and NCLXWT (n = 5) are 3.5- and 3-fold faster than NCLXS258A (n = 11), respectively.
(F) Representative fluorescence traces of Na+-dependent mCa
2+ efflux in digitonin-permeabilized HEK293T cells transiently expressing the mCa
2+ sensor mito-
Pericam, NCLX shRNA, and NCLXWT or mutant NCLX (NCLXS258A or NCLXS258D).
(G) Quantification of mCa
2+ efflux rates of (F). Similar to Figure 3E, NCLXS258D (n = 3) and NCLXWT (n = 6) are more than 2-fold faster than NCLXS258A (n = 4). All bar
graph data represent mean ± SEM. *p < 0.05, **p < 0.01. See also Figure S2 and Table S1.described (Palty et al., 2010). Consistent with our finding in intact
cells, silencing of endogenous NCLX profoundly inhibited the
Na+-dependent Ca2+ efflux, which was fully rescued by overex-
pression of either NCLXS258D or NCLXWT (Figures 3F and 3G;
Figure S2C). In contrast, the NCLXS258A mutant, although380 Cell Reports 13, 376–386, October 13, 2015 ª2015 The Authorsdemonstrating some residual activity, was inhibited by more
than 2-fold compared to either NCLXS258D or NCLXWT (Figures
3F and 3G).
Taken together, these results indicate that phosphorylation at
S258 mediates the effects of PKA on mCa
2+ efflux.
Figure 4. Phosphomimetic Mutants of NCLX Rescue mCa
2+ Ho-
meostasis in PINK1-Deficient Cells Independent of PKA
(A) Representative fluorescence traces of mCa
2+ responses upon application
of ATP to HEK293T cells transiently expressing the mCa
2+ sensor mito-Peri-
cam, NCLX shRNA, and NCLXWT ormutant NCLX (NCLXS258A or NCLXS258D) in
the absence or presence of forskolin.
(B) Averaged rates of mCa
2+ efflux of data in (A). A minimum of n = 5 inde-
pendent experiments for all quantified data. Note that the mutants NCLXS258A
and NCLXS258D, unlike NCLXWT, are not responsive to forskolin.
(C) Representative fluorescence traces of mCa
2+ responses in shPINK1 SH-
SY5Y cells overexpressing NCLXWT, NCLXS258A, and NCLXS258D, or non-
transfected shPINK1 SH-SY5Y cells loaded with 5 mMRhod-2 AM. Application
of 100 mM ATP triggered mCa
2+ transients.
(D) Averaged mCa
2+ efflux rates of (C). Constitutively active mutant NCLXS258D
(n = 9) and NCLXWT (n = 3), in contrast to inactive NCLXS258A (n = 9), are able to
overcome the inhibitory effect of PINK1 deficiency on mCa
2+ removal. All bar
graph data represent mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001.Expression of Phosphomimetic NCLXS258D, but Not
Phosphodeficient NCLXS258A, Suppresses the Inhibitory
Effect of PINK1 Deficiency on mCa
2+ Efflux
If the S258 residue is the critical site regulated by PKA, then ex-
pressing the constitutively active NCLXS258D or the inactive
NCLXS258A mutant is expected to eliminate, in both cases, the
responsiveness to forskolin that we observed for the endoge-
nous NCLX (Figures 2C and 2E). Consistent with previous find-
ings, we confirmed that NCLXWT is responsive to PKA activation
and activates by 2-fold when treated with forskolin (Figures 4A
and 4B). On the other hand, activity of NCLXS258A in the presence
of forskolin remained low and that of NCLXS258D was constitu-
tively high, in agreement with their inactivation and activation
phenotypes, respectively (Figures 4A and 4B).
If phosphorylation of NCLX at the PKA site, S258, is required
for activation of mCa
2+ efflux, NCLXS258D should remain acti-
vated compared to NCLXS258A when expressed in shPINK1
SH-SY5Y cells. Indeed, mCa
2+ efflux rates of shPINK1 SH-
SY5Y cells expressing phosphomimetic mutant NCLXS258D
were almost 2-fold higher than the rates recorded in cells ex-
pressing phosphodeficient NCLXS258A (Figures 4C and 4D).
Note that NCLXWT was also active in shPINK1 cells, indicatingCthat the residual PKA activity observed in these cells is sufficient
to activate NCLX, consistent with the critical role of intact S258
for its activation, and further showing that higher heterologous
expression of NCLXWT can compensate for lesser PKA activity.
Thus, modulation of the S258 site is essential and sufficient to
fully recover mCa
2+ efflux rates from the inhibitory effect
observed in PINK1-deficient SH-SY5Y cells.
NCLX Phosphomimetics Also Rescues mCa
2+ Overload
in PINK1 Knockout Neurons
To determine the effect of the NCLX mutants in PINK1 knockout
(KO) mouse neurons, intact neurons were loaded with the Ca2+
indicator X-Rhod-1 and mCa
2+ was assessed upon provision of
a physiological stimulus (Figure 5A). It should be noted that
X-Rhod-1 labels mitochondrial as well as cytosolic Ca2+. How-
ever, only mitochondrial areas were selected for analysis (Fig-
ure S3). We stimulated either WT or PINK1 KO neurons with
1 mM glutamate, which caused a transient increase in cytosolic
Ca2+, followed by changes in mCa
2+, as mitochondria buffer
this surge in cytosolic Ca2+ (Figure 5B). PINK1 KOcells displayed
a markedly reduced mCa
2+ efflux rate, by 10-fold compared to
WT neurons (Figures 5C and 5D). However, mitochondria of
PINK1 KO cells overexpressing NCLXS258D and NCLXWT dis-
played faster Ca2+ exclusion rates, similar to those observed in
WT neurons (Figures 5C and 5D). In contrast, overexpression
of NCLXS258A failed to rescue the aberrant mCa
2+ efflux in
PINK1 KO neurons (Figures 5C and 5D).
To eliminate any differences in mCa
2+ handling due to varying
cytosolic Ca2+ responses, cells were permeabilized in pseudoin-
tracellular medium after X-Rhod-1 loading. Permeabilization of
neurons allowed for precise control over Ca2+ concentrations
outside of the mitochondria and direct measurement of mCa
2+
handling (Figure 5E). Application of 5 mM Ca2+ led to a transient
increase and exclusion of mCa
2+ within 0.5–1 min in WT cells
(Figures 5F and 5G). In agreement with previous data (Abramov
et al., 2011; Gandhi et al., 2009), deletion of PINK1 led to altered
mCa
2+ efflux, mirroring that observed in whole-cell experiments
(Figures 5F and 5G). Similar to our results in intact PINK1 KO
neurons, overexpression of NCLXS258D or NCLXWT rescued the
mCa
2+ efflux in permeabilized neurons when compared to either
PINK1 KO or PINK1 KO NCLXS258A-expressing cells (Figures 5F
and 5G).
Mitochondrial Membrane Potential Is Rescued through
Overexpression of NCLXS258D but Not of the NCLXS258A
Mutant
Normalization of DJm in PINK1 KO cells by pyruvate and succi-
nate did not change the inhibited Na+/Ca2+ exchange in these
cells (Gandhi et al., 2009), suggesting that it is not the most up-
stream mechanism by which PINK1 deficiency affects mCa
2+
efflux. Because excess mitochondrial matrix Ca2+ can trigger
the loss of membrane potential (Vergun and Reynolds, 2005),
we studied whether a recovery of mCa
2+ efflux via PKA-mediated
activation of NCLX could lead to a rescue of DJm in PINK1 KO
neurons.
As expected, PINK1 KO neurons possessed significantly
reduced DJm (77% ± 5% of WT control) (Figure 6A). We first
checked whether PKA activation by forskolin can suppress thisell Reports 13, 376–386, October 13, 2015 ª2015 The Authors 381
Figure 5. Phosphomimetic Mutant NCLXS258D, in Contrast to Phosphodeficient NCLXS258A, Rescues mCa
2+ Efflux in PINK1 KO Neurons
(A) Image of a whole neuron loaded with X-Rhod-1 AM. The scale bar represents 10 mm.
(B) Representative traces of mCa
2+ response upon glutamate stimulation in intact neurons. Note the inhibition of mCa
2+ efflux in PINK1 KO neurons compared to
WT neurons.
(C and D) Representative traces and quantification of the mCa
2+ efflux upon glutamate stimulation in intact WT (n = 11), PINK1 KO (n = 3), or PINK1 KO neurons
overexpressing either NCLXS258A (n = 4), NCLXS258D (n = 4), or NCLXWT (n = 11).
(E) Images of permeabilized neurons that were loaded with X-Rhod-1 before and after Ca2+ stimulation. The scale bars represent 10 mm.
(F and G) Representative traces and quantification of mCa
2+ efflux upon Ca2+ stimulation in permeabilized PINK1 KO neurons (n = 9) and PINK1 KO neurons
overexpressing NCLXWT (n = 7), NCLXS258A (n = 11), or NCLXS258D (n = 6), respectively. All bar graph data represent mean ± SEM. *p < 0.05, **p < 0.01, ***p <
0.001. See also Figure S3.reduction in DJm. Similar to the effect observed in PINK1-defi-
cient SH-SY5Y cells (Figures 2A and 2B), we observed a full
rescue of DJm in PINK1 KO neurons in the presence of forskolin
(Figure 6A).
We then asked whether expression of phosphomimetic
NCLXS258D or NCLXWT could recover DJm in PINK1 KO neu-
rons. Notably, overexpression of NCLXS258D and NCLXWT
restored DJm in PINK1 KO cells back to its level in WT neurons
(104% ± 8% and 110% ± 12% of WT control, respectively) (Fig-
ure 6B). In contrast, NCLXS258A expression in PINK1 KO failed to
restore the DJm (72% ± 5% of WT control) (Figure 6B).
NCLXS258D but Not NCLXS258A Overexpression Protects
PINK1 KO Neurons from Dopamine-Induced Cell Death
The mCa
2+ dysregulation and overload can trigger premature
opening of the mitochondrial permeability transition pore
(mPTP) and cell death (Crompton, 1999; Nicholls and Budd,
2000). We reasoned that, by rescuing both mCa
2+ efflux and
DJm, phosphomimicking mutant NCLXS258D, but not
NCLXS258A, should prevent the opening of mPTP and increase
neuronal survival of PINK1 KO neurons. PINK1 KO cells are
prone to dopamine-induced cell toxicity, and incubation of
PINK1 KO midbrain cultures with 50 mM dopamine triggered382 Cell Reports 13, 376–386, October 13, 2015 ª2015 The Authorscell death (73% ± 3%), which was significantly higher compared
to control PINK1 KO neurons not treated with dopamine (3% ±
1%), consistent with previous results (Gandhi et al., 2012) (Fig-
ure 6C). In accordance with our hypothesis, expression of
NCLXS258A failed to have an effect (66% ± 2%), whereas expres-
sion of both NCLXS258D and NCLXWT significantly reduced dopa-
mine-induced cell death of PINK1 KO neurons (49% ± 4% and
45% ± 3, respectively) (Figure 6C).
DISCUSSION
Loss-of-function mutations of PINK1, a mitochondrially targeted
serine/threonine kinase, are linked to recessively inherited PD
(Gandhi et al., 2009; Valente et al., 2004). A major hallmark of
PINK1 deficiency in neurons is an mCa
2+ overload, which leads
to neuronal cell death triggered by the opening of mPTP (Abra-
mov et al., 2011; Akundi et al., 2011; Gandhi et al., 2009; Gautier
et al., 2008). Previous findings suggested that the mCa
2+ over-
load related to the loss of PINK1 occurs due to specific inhibition
of mCa
2+ efflux from dopaminergic neurons (Gandhi et al., 2009).
The prevailing route of Ca2+ efflux from neuronal mitochondria is
its exchange with Na+ via the mitochondrial Na+/Ca2+ exchanger
NCLX (Gunter et al., 2000). Loss of PINK1, however, strongly
Figure 6. NCLXS258D Overexpression Re-
storesDJm in PINK1 KONeurons and Res-
cues Them from Dopamine-Induced Cell
Death
(A) Quantification of basal DJm in WT (n = 6) and
PINK1 KO (n = 16) neurons in the absence and
presence of forskolin. Note that forskolin treat-
ment reduces mitochondrial depolarization of
PINK1 KO neurons to control values.
(B) Quantification of basalDJm inWT neurons (n =
6), PINK1 KO neurons (n = 22), and PINK1 KO
neurons overexpressing NCLXWT (n = 9), consti-
tutively active NCLXS258D (n = 6), and inactive
NCLXS258A (n = 4) constructs.
(C) Quantification of dopamine-induced cell death
in PINK1 KO neurons (n = 12) and PINK1 KO
neurons overexpressing NCLXWT (n = 10), consti-
tutively active NCLXS258D (n = 9), and inactive
NCLXS258A (n = 13) constructs. All bar graph data
represent mean ±SEM. *p < 0.05, **p < 0.01, ***p <
0.001.inhibits exchange activity, as neither mCa
2+ removal nor
concomitant mitochondrial Na+ influx is observed upon trig-
gering mCa
2+ influx in PINK1 KO neurons (Gandhi et al., 2009).
Here we confirm that the mCa
2+ efflux is significantly reduced
in PINK1 KO mouse dopaminergic neurons and, furthermore,
we demonstrate a similar inhibition of mCa
2+ efflux by stably
knocking down PINK1 in a human neuroblastoma cell line (SH-
SY5Y). The inhibition of mCa
2+ efflux could be mediated either
by a direct interaction/phosphorylation of PINK1 with NCLX or
by an indirect effect of PINK1 loss that communicates with
NCLX through a distinct pathway (Figure 7). The following results
argue against a direct interaction of NCLX and PINK1: (1) bio-
informatic analysis failed to identify any PINK1 phosphorylation
site on NCLX; (2) proteomic analysis of PINK1-interacting pro-
teins found 14 candidates, but NCLX was not among them (Ra-
kovic et al., 2011); and (3) our MS analysis of overexpressed
NCLX failed to identify interaction with PINK1 or phosphorylation
of NCLX related to this kinase (Table S1).
Recent studies, however, indicate that loss of PINK1 leads to
PKA inhibition (Dagda et al., 2014). We show that PKA strongly
modulates mCa
2+ efflux. This effect can be mediated indirectly
or by PKA-dependent phosphorylation of NCLX. The following
results support the latter mechanism. (1) The inclusion of a
PKA inhibitor abolished the forskolin-dependent upregulation
of NCLX activity. Our findings are consistent with early studies
demonstrating a cAMP-dependent upregulation of Na+-depen-
dent mCa
2+ efflux (Goldstone and Crompton, 1982). (2) NCLX
harbors a potential PKA phosphorylation site at S258, which
we now show by MS analysis is phosphorylated by activation
of PKA in cells and directly by PKA in an in vitro purified NCLX
preparation (Figure 3B). Importantly, when S258 is replaced by
aspartate (NCLXS258D), mCa
2+ efflux by NCLX is enhanced,
whereas changing it to alanine (NCLXS258A) downregulates
mCa
2+ efflux. (3) The activity of NCLXS258D and NCLXS258A isCnonresponsive to the PKA agonist, indicating that S258 is indeed
the target site for PKA on NCLX (Figure 7). The S258 residue of
NCLX is described here as a regulatory switch in this exchanger,
and phosphorylation at this site represents a mode of regulation
for mitochondrial Na+/Ca2+ exchange. Furthermore, our results
indicate that mimicking phosphorylation of S258 plays a key
role in preventing mCa
2+ overload in several injury paradigms,
and may therefore be an attractive therapeutic target. Notably,
overexpression of NCLXWT can also overcome the downregula-
tion of NCLX activity in PINK1-deficient cells. This finding is
consistent with the partial inhibition of PKA following PINK1
knockdown (Dagda et al., 2014). Thus, overexpression of
NCLXWT may increase the availability of the regulatory site to
PKA. Indeed, overexpression of the inactive NCLXS258A failed
to produce a similar activation, strongly supporting the regulato-
ry importance of this site (Figure 7).
Plasma membrane NCXs possess a regulatory mechanism
involving cytosolic Ca2+ that is well defined. NCX has a long
intracellular loop that carries two Ca2+-binding domains (CBD1
and CBD2) that strongly and allosterically regulate NCX following
changes in cytosolic Ca2+ (Nicoll et al., 2013). However, the ho-
mologous hydrophilic loop of NCLX is much shorter and lacks
any obvious Ca2+-binding domains. In contrast, it possesses
the PKA phosphorylation site defined in the current study. Our
results therefore indicate that NCLX has an entirely different
mode of regulation compared to the plasma membrane
NCXs—it is based on phosphorylation, not on allosteric Ca2+
binding.
Two distinct pools of cAMP/PKA signaling mediators are
capable of reaching and regulating mitochondria. The first is
associated with cytosolic cAMP that is produced by cell mem-
brane adenylyl cyclase, which can activate PKA, allowing it to
translocate to the outer mitochondrial membrane and intermem-
brane space (Lefkimmiatis et al., 2013). The second is generatedell Reports 13, 376–386, October 13, 2015 ª2015 The Authors 383
Figure 7. Schematic Diagram Illustrating
the Link between PINK1 Deficiency and
PKA-Mediated Rescue of mCa
2+Dyshomeo-
stasis and Ultimately Neuronal Fate
PINK1 deficiency leads to mitochondrial damage
and depolarization, leading to inhibition of the Na+/
Ca2+ exchanger NCLX, the major Ca2+ efflux
pathway in mitochondria. The resulting buildup of
mCa
2+ overload, combined with mitochondrial
depolarization, can result in the opening of the
mitochondrial permeability transition pore. PKA
independent of PINK1 activates NCLX via phos-
phorylation at S258. Phosphorylation of NCLX
rescues its activity in PINK1-deficient neurons and
stops this vicious cycle, leading to recovery of
mitochondrial membrane potential, thus
enhancing dopaminergic neuronal survival.by a soluble adenylyl cyclase that is solely contained in the mito-
chondrial matrix (Acin-Perez et al., 2009; Di Benedetto et al.,
2013). Although the sensitivity of cytosolic PKA to forskolin sug-
gests its role in NCLX regulation, further studies are required to
determine the subcellular origin of PKA species that participate
in NCLX regulation.
Another distinctive aspect of PINK1 deficiency in neurons is a
partial mitochondrial depolarization, which significantly contrib-
utes to the increased neuronal death related to PINK1 loss (Abra-
mov et al., 2011; Dagda et al., 2011). The reducedDJm in PINK1
KO neurons can be restored by provision of substrates of mito-
chondrial respiratory chain complexes I and II. However, this
rescue of DJm does not recover mCa
2+ efflux deficits, suggest-
ing that the inhibition of the exchanger is upstream of the mito-
chondrial depolarization. Here we demonstrate that mCa
2+ efflux
can be fully reconstituted by expression of constitutively active
mutant NCLXS258D, which furthermore fully rescues DJm in
PINK1 KO neurons. These results imply that the impairment of
mCa
2+ shuttling is due to diminished NCLX activity encountered
in PINK1 deficiency, which in turn contributes, at least in part, to
the mitochondrial depolarization.
Interestingly, we previously found that PINK1-deficient cells
exhibit reduced PKA signaling (Dagda et al., 2014). Although it
is possible that the two pathways operate in parallel, PINK1
and PKA exhibit features of a positive amplifying interaction.
Loss of PINK1 selectively suppresses the ability of cAMP, but
not retinoic acid, to induce neuronal differentiation (Dagda
et al., 2014). This is accompanied by decreased indices of PKA
activity (CRE-luciferase and CREB phosphorylation) in PINK1
shRNA cells (Dagda et al., 2014). Conversely, PINK1 overexpres-
sion elevates CRE activity and enhances neurite outgrowth;
these effects of PINK1 are inhibited byH89 or expression of ami-
tochondrially targeted peptide inhibitor of PKA (Dagda et al.,
2014). These data suggest that PINK1 is necessary for full activ-
ity of PKA at the mitochondrion. Thus, the reduction in NCLX ac-
tivity observed in PINK1-deficient cells and neurons could be
due to reduced PKA activation in these cells (Figure 7). Although
it is possible that PINK1 deficiency also affects other parallel384 Cell Reports 13, 376–386, October 13, 2015 ª2015 The Authorspathways, our current results clearly indicate that PKA-mediated
upregulation of NCLX activity can break these vicious cycles in
PINK1-deficient neurons to rescue not only the mCa
2+ overload
but also the DJm (Figure 7).
One would expect that by rescuing both mCa
2+ efflux and
DJm, expression of the constitutively active exchanger
NCLXS258D would result in reduced neuronal cell death related
to PINK1 deficiency. Indeed, we recorded a significant increase
in neuronal survival rate upon expression of NCLXS258D or
NCLXWT, but not NCLXS258A, implying that modulation of the
NCLX phosphorylation site by PKA activation is essential and
sufficient to protect PINK1-deficient neurons from dopamine-
induced cell death. Taken together, our results establish NCLX
as the major player implicated in several mitochondrial defects
related to PD caused by PINK1 impairment.
Mitochondria play amajor role in the regulation of cellular Ca2+
homeostasis (De Smedt et al., 2011). Impairment of mCa
2+ shut-
tling results in mCa
2+ overload similar to that related to PINK1
deficiency, which is implicated in a range of neurodegenerative
and ischemic diseases. This notion further highlights the impor-
tance of the exchanger and the regulatory mechanism via PKA
described in this paper. Under physiological conditions in the
steady state, NCLX andMCUCa2+ transport must be in balance.
Under pathophysiological conditions, however, mCa
2+ overload
can occur either as a result of increased mCa
2+ uptake via
MCU or reduced mCa
2+ removal via NCLX, as observed in
PINK1-deficient cells (Gandhi et al., 2009). In the latter case, acti-
vation of NCLX via the PKA regulatory pathway leads to a recov-
ery of impaired mCa
2+ handling and neuronal rescue (Figure 7),
which opens new avenues for future targeted therapeutic strate-
gies for these disorders.EXPERIMENTAL PROCEDURES
Mice
Wild-type and PINK1 KO mice were from breeding colonies generated by
Lexicon Genetics. Animal breeding and maintenance were in accordance
with the regulations described in UK Animals (Scientific Procedures) Act 1986.
Cell Culture and Transfection
HEK293T cells were as previously described (Palty et al., 2004). Stable PINK1
shRNA knockdown SH-SY5Y cell lines were generated and cultured as previ-
ously described (Dagda et al., 2009). Primary midbrain mouse neurons were
isolated and cultured as previously described (Gandhi et al., 2009). Transfec-
tion of HEK293T cells was performed using the calcium phosphate precipita-
tion protocol as previously described (Palty et al., 2004). SH-SY5Y cells and
primary neuronal cells were transfected using Lipofectamine 2000 (Invitrogen)
and Effectine (QIAGEN), respectively, according to the manufacturers’
protocols.
Immunoblot Analysis
NCLX and PINK1 immunoblotting was performed as previously reported (Palty
et al., 2010). For specific determination of NCLX expression in mitochondria,
cell fractionation was performed as previously described (Bozidis et al.,
2007). Immunoblot analysis was performed as described previously (Palty
et al., 2010) using the following antibodies: custom-made antibody against
NCLX (Palty et al., 2004; 1:1,000), rabbit polyclonal anti-PINK1 antibody
(Abcam; 1:200), anti-b-actin (Sigma; 1:20,000), and anti-cytochrome c oxidase
(COXIV-1) antibody (Santa Cruz Biotechnology; 1:100).
Immunoprecipitation and MS Analysis
HEK293T cells were transfected with a c-myc-tagged human NCLX-encoding
plasmid. Forty-eight hours posttransfection, cells were incubated with forsko-
lin or cotreated with H89 and forskolin and then lysed in the presence of pro-
tease inhibitors (Sigma) and phosphatase inhibitors (PhosSTOP; Roche), and
the lysate was immunoprecipitated with anti-c-myc agarose beads (Pierce
Anti-c-Myc agarose; Thermo Scientific) using the manufacturer’s protocol.
On-bead tryptic proteolysis and MS were performed as previously described
(Fukuyama et al., 2012).
Fluorescent Ca2+ and DJm Imaging
In HEK293T cells, the mCa
2+ levels were monitored by transiently expressed
mitochondrially targeted ratiometric Pericam (mito-Pericam) as previously
described (Palty et al., 2010). The mCa
2+ measurement in SH-SY5Y cells
was performed using Rhod-2 AM fluorescent Ca2+ dye as previously
described (Jaiswal et al., 2009). Changes in inner DJm were monitored using
TMRM as previously described (Nita et al., 2012).
Confocal Imaging
Confocal images of X-Rhod-1-loaded neurons were obtained as previously
described (Gandhi et al., 2009).
Toxicity Experiments
For toxicity assays, we loaded cells simultaneously with 20 mM propidium io-
dide, which is excluded from viable cells but exhibits a red fluorescence
following a loss of membrane integrity, and 4.5 mM Hoechst 33342 (Molecular
Probes), which gives a blue staining to chromatin, to count the total number of
cells.
Statistical Analysis
All results are presented as mean ± SEM. Statistical significance was deter-
mined using t test or one-way ANOVA test followed by Tukey post hoc anal-
ysis. Values of p <0.05 were considered significant.
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